Coronary drug-eluting stent development: issues in trial design

Am Heart J. 2005 Mar;149(3):415-33. doi: 10.1016/j.ahj.2004.09.001.
No abstract available

MeSH terms

  • Animals
  • Clinical Trials as Topic / methods*
  • Coronary Restenosis / diagnosis
  • Coronary Restenosis / etiology
  • Coronary Stenosis / therapy
  • Drug Delivery Systems / methods*
  • Equipment Design
  • Humans
  • Maximum Tolerated Dose
  • Models, Animal
  • Pharmacokinetics
  • Product Surveillance, Postmarketing / methods*
  • Recurrence
  • Research Design
  • Stents* / adverse effects